Committed to developing treatments
for orphan diseases

Laurent Pharmaceuticals is an orphan drug company with a clinical development program in cystic fibrosis.  

laurent Lauren2 Laurent3

Cystic Fibrosis

    Science

 LAU-7b

Events

Laurent Pharmaceuticals to participate at the NACFC 2018October 18th-20th 2018, Denver, Colorado, USA

Laurent Pharmaceuticals to participate at RESI NYC 2018, November 5th 2018, New York City, USA

 

News

Laurent Pharmaceuticals reaches agreement with US Cystic Fibrosis Foundation to increase Development Award to $US 5M

Read more  

Laurent Pharmaceuticals Receives FDA and Health Canada Clearance to Initiate APPLAUD Phase 2 Clinical Study of LAU-7b for the Treatment of Cystic Fibrosis

Read more